<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32968168</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Sep</Month><Day>23</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>The 6-min walk test as a new outcome measure in Amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>15580</StartPage><MedlinePgn>15580</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">15580</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-020-72578-3</ELocationID><Abstract><AbstractText>One of the issues highlighted in amyotrophic lateral sclerosis (ALS) clinical trials is the lack of appropriate outcome measures. The aim of this multicentric study was to evaluate the 6-min walk test (6MWT) as tool to monitor the natural history of a cohort of ALS patients followed up over a 6-month interval. Forty-four ambulant patients were assessed at baseline and after 1, 3 and 6&#xa0;months. Eight out of forty-four lost the ability to walk before the end of the study. The 6MWT and the objective measures linked to motor function, such as 10&#xa0;m walking test (10MWT) and Time-up and go (TUG), the ALSFRS-R and the ALSFRS-R items 7-9 showed a good responsiveness to change over the 6-month interval. There was a strong correlation between 6 and 10MWT, TUG, ALSFRS-R, ALSFRS-R items 7-9 and FVC% at baseline. There was no correlation with Edinburgh Cognitive and Behavioural ALS Screen (ECAS) and Modified Borg Scale (MBS). The &#x394; of 6MWT from T0 to T6 significantly correlated with the &#x394;s of 10MWT and TUG. There was no correlation with the &#x394;s of ALSFRS-R, ALSFRS-R items 7 9, ECAS, MBS and FVC%. The discordance between changes of the 6MWT and ALSFRS-R at 6&#xa0;month highlights the different content validity among these instruments. The concordance among 6MWT, 10MWT and TUG indicates that the 6MWT is an objective, sensitive and robust tool to measure motor performances in a longitudinal setting. The main limitations of our study were the small sample size and the high percentage of patients (18%) lost at follow-up. Therefore, further studies on larger cohorts, and exploring the relation between 6MWT and need of ventilator support or survival could strengthen our results.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Russo</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unit of Neurology and Neuromuscular Disorders, Department of Clinical and Experimental Medicine, University of Messina, AOU Policlinico "G. Martino", 98125, Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lunetta</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>NEuroMuscular Omnicentre of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuccarino</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>NEuroMuscular Omnicentre of Arenzano, Arenzano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vita</LastName><ForeName>Gian L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>NEuroMuscular Omnicentre of Messina, University Hospital "G. Martino", Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sframeli</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>NEuroMuscular Omnicentre of Messina, University Hospital "G. Martino", Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lizio</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>NEuroMuscular Omnicentre of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>La Foresta</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>NEuroMuscular Omnicentre of Messina, University Hospital "G. Martino", Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faraone</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>NEuroMuscular Omnicentre of Messina, University Hospital "G. Martino", Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sansone</LastName><ForeName>Valeria A</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>NEuroMuscular Omnicentre of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurorehabilitation Unit, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vita</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Unit of Neurology and Neuromuscular Disorders, Department of Clinical and Experimental Medicine, University of Messina, AOU Policlinico "G. Martino", 98125, Messina, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NEuroMuscular Omnicentre of Messina, University Hospital "G. Martino", Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messina</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Unit of Neurology and Neuromuscular Disorders, Department of Clinical and Experimental Medicine, University of Messina, AOU Policlinico "G. Martino", 98125, Messina, Italy. smessina@unime.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NEuroMuscular Omnicentre of Messina, University Hospital "G. Martino", Messina, Italy. smessina@unime.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="Y">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000070857" MajorTopicYN="N">Walk Test</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016138" MajorTopicYN="N">Walking</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>24</Day><Hour>5</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32968168</ArticleId><ArticleId IdType="pmc">PMC7511965</ArticleId><ArticleId IdType="doi">10.1038/s41598-020-72578-3</ArticleId><ArticleId IdType="pii">10.1038/s41598-020-72578-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kiernan MC, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Hammond ER, Mora G, Bonito V, Filippini G. Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2015;86(1):38&#x2013;44. doi: 10.1136/jnnp-2013-306589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-306589</ArticleId><ArticleId IdType="pubmed">24336810</ArticleId></ArticleIdList></Reference><Reference><Citation>Ada L, Dean CM, Lindley R, Lloyd G. Improving community ambulation after stroke: the AMBULATE Trial. BMC Neurol. 2009;9:8. doi: 10.1186/1471-2377-9-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-9-8</ArticleId><ArticleId IdType="pmc">PMC2650676</ArticleId><ArticleId IdType="pubmed">19208261</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, et al. Non-self-sufficiency as a primary outcome measure in ALS trials. Amyotroph. Lateral Scler. Frontotemporal Degener. 2015;17(1&#x2013;2):77&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">26470831</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo A, Moglia C, Lunetta C, et al. Factors predicting survival in ALS: a multicenter Italian study. J. Neurol. 2017;264(1):54&#x2013;63. doi: 10.1007/s00415-016-8313-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-016-8313-y</ArticleId><ArticleId IdType="pubmed">27778156</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbeau H, et al. Comparison of speeds used for the 15.2-meter and 6-minute walks over the year after an incomplete spinal cord injury: the SCILT Trial. Neurorehabil. Neural Repair. 2007;21(4):302&#x2013;306. doi: 10.1177/1545968306298937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1545968306298937</ArticleId><ArticleId IdType="pmc">PMC4067131</ArticleId><ArticleId IdType="pubmed">17369517</ArticleId></ArticleIdList></Reference><Reference><Citation>Canning CG, Ada L, Johnson JJ, McWhirter S. Walking capacity in mild to moderate Parkinson&#x2019;s disease. Arch. Phys. Med. Rehabil. 2006;87(3):371&#x2013;375. doi: 10.1016/j.apmr.2005.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2005.11.021</ArticleId><ArticleId IdType="pubmed">16500171</ArticleId></ArticleIdList></Reference><Reference><Citation>Duncan P, et al. A randomized, controlled pilot study of a home-based exercise program for individuals with mild and moderate stroke. Stroke. 1998;29(10):2055&#x2013;2060. doi: 10.1161/01.STR.29.10.2055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.29.10.2055</ArticleId><ArticleId IdType="pubmed">9756581</ArticleId></ArticleIdList></Reference><Reference><Citation>Eng JJ, Chu KS, Dawson AS, Kim CM, Hepburn KE. Functional walk tests in individuals with stroke: relation to perceived exertion and myocardial exertion. Stroke. 2002;33(3):756&#x2013;761. doi: 10.1161/hs0302.104195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/hs0302.104195</ArticleId><ArticleId IdType="pubmed">11872900</ArticleId></ArticleIdList></Reference><Reference><Citation>Savci S, et al. Six-minute walk distance as a measure of functional exercise capacity in multiple sclerosis. Disabil. Rehabil. 2005;27(22):1365&#x2013;1371. doi: 10.1080/09638280500164479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09638280500164479</ArticleId><ArticleId IdType="pubmed">16372431</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannerkorpi K, Svantesson U, Broberg C. Relationships between performance-based tests and patients' ratings of activity limitations, self-efficacy, and pain in fibromyalgia. Arch. Phys. Med. Rehabil. 2006;87(2):259&#x2013;264. doi: 10.1016/j.apmr.2005.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2005.10.013</ArticleId><ArticleId IdType="pubmed">16442982</ArticleId></ArticleIdList></Reference><Reference><Citation>Kierkegaard M, Tollb&#xe4;ck A. Reliability and feasibility of the six minute walk test in subjects with myotonic dystrophy. Neuromuscul. Disord. 2007;17(11&#x2013;12):943&#x2013;949. doi: 10.1016/j.nmd.2007.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2007.08.003</ArticleId><ArticleId IdType="pubmed">17869516</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi Y, et al. Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy. Muscle Nerve. 2008;38(2):964&#x2013;971. doi: 10.1002/mus.21077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21077</ArticleId><ArticleId IdType="pubmed">18642379</ArticleId></ArticleIdList></Reference><Reference><Citation>Gylfadottir S, Dallimore M, Dean E. The relation between walking capacity and clinical correlates in survivors of chronic spinal poliomyelitis. Arch. Phys. Med. Rehabil. 2006;87(7):944&#x2013;952. doi: 10.1016/j.apmr.2006.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2006.03.014</ArticleId><ArticleId IdType="pubmed">16813782</ArticleId></ArticleIdList></Reference><Reference><Citation>Wokke JH, et al. Clinical features of late-onset Pompe disease: a prospective cohort study. Muscle Nerve. 2008;38(4):1236&#x2013;1245. doi: 10.1002/mus.21025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21025</ArticleId><ArticleId IdType="pubmed">18816591</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P, Burger H, Marincek C, Meh D. Influence of foot pain on walking ability of diabetic patients. J. Rehabil. Med. 2004;36(6):249&#x2013;252. doi: 10.1080/16501970410029816.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/16501970410029816</ArticleId><ArticleId IdType="pubmed">15841600</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald CM, et al. The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study. Muscle Nerve. 2013;48(3):357&#x2013;368. doi: 10.1002/mus.23905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.23905</ArticleId><ArticleId IdType="pmc">PMC3826053</ArticleId><ArticleId IdType="pubmed">23674289</ArticleId></ArticleIdList></Reference><Reference><Citation>Spina E, et al. Six-minute walk test is reliable and sensitive in detecting response to therapy in CIDP. J. Neurol. 2019;266(4):860&#x2013;865. doi: 10.1007/s00415-019-09207-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09207-1</ArticleId><ArticleId IdType="pubmed">30721354</ArticleId></ArticleIdList></Reference><Reference><Citation>Padua L, et al. Novel outcome measures for Charcot&#x2013;Marie&#x2013;Tooth disease: validation and reliability of the 6-min walk test and StepWatch(TM) Activity Monitor and identification of the walking features related to higher quality of life. Eur. J. Neurol. 2016;23(8):1343&#x2013;1350. doi: 10.1111/ene.13033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13033</ArticleId><ArticleId IdType="pubmed">27160471</ArticleId></ArticleIdList></Reference><Reference><Citation>Pazzaglia C, et al. Are novel outcome measures for Charcot&#x2013;Marie&#x2013;Tooth disease sensitive to change? The 6-minute walk test and StepWatch(TM) Activity Monitor in a 12-month longitudinal study. Neuromuscul. Disord. 2019;29(4):310&#x2013;316. doi: 10.1016/j.nmd.2019.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2019.01.009</ArticleId><ArticleId IdType="pubmed">30926199</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanjak M, et al. Six-minute walk test as a measure of walking capacity in ambulatory individuals with amyotrophic lateral sclerosis. Arch. Phys. Med. Rehabil. 2017;98(11):2301&#x2013;2307. doi: 10.1016/j.apmr.2017.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2017.04.004</ArticleId><ArticleId IdType="pubmed">28465220</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S, Cudkowicz M, Berry JD. Outcome measures in amyotrophic lateral sclerosis clinical trials. Clin. Investig. 2014;4(7):605&#x2013;618. doi: 10.4155/cli.14.52.</Citation><ArticleIdList><ArticleId IdType="doi">10.4155/cli.14.52</ArticleId><ArticleId IdType="pmc">PMC5305182</ArticleId><ArticleId IdType="pubmed">28203356</ArticleId></ArticleIdList></Reference><Reference><Citation>Andres PL, et al. Fixed dynamometry is more sensitive than vital capacity or ALS rating scale. Muscle Nerve. 2017;56(4):710&#x2013;715. doi: 10.1002/mus.25586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.25586</ArticleId><ArticleId IdType="pubmed">28120413</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedlack RS, et al. How common are ALS plateaus and reversals? Neurology. 2016;86(9):808&#x2013;812. doi: 10.1212/WNL.0000000000002251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002251</ArticleId><ArticleId IdType="pmc">PMC4793781</ArticleId><ArticleId IdType="pubmed">26658909</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner JM, et al. Quantitative strength testing in ALS clinical trials. Neurology. 2016;87(6):617&#x2013;624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4977369</ArticleId><ArticleId IdType="pubmed">27385750</ArticleId></ArticleIdList></Reference><Reference><Citation>Fournier CN, et al. Development and validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) JAMA Neurol. 2019;77(4):480&#x2013;488. doi: 10.1001/jamaneurol.2019.4490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.4490</ArticleId><ArticleId IdType="pmc">PMC6990811</ArticleId><ArticleId IdType="pubmed">31886839</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marchi F, et al. Patient reported outcome measures (PROMs) in amyotrophic lateral sclerosis. J. Neurol. 2020;267(6):1754&#x2013;1759. doi: 10.1007/s00415-020-09774-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09774-8</ArticleId><ArticleId IdType="pubmed">32125520</ArticleId></ArticleIdList></Reference><Reference><Citation>ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories ATS statement: guidelines for the six-minute walk test. Am. J. Respir. Crit. Care Med. 2002;166(1):111&#x2013;117. doi: 10.1164/ajrccm.166.1.at1102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.166.1.at1102</ArticleId><ArticleId IdType="pubmed">12091180</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina S, et al. Health-related quality of life and functional changes in DMD: a 12-month longitudinal cohort study. Neuromuscul. Disord. 2016;26(3):189&#x2013;196. doi: 10.1016/j.nmd.2016.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2016.01.003</ArticleId><ArticleId IdType="pmc">PMC4819956</ArticleId><ArticleId IdType="pubmed">26916554</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzone E, et al. North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy. Neuromuscul. Disord. 2010;20(11):712&#x2013;716. doi: 10.1016/j.nmd.2010.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2010.06.014</ArticleId><ArticleId IdType="pubmed">20634072</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercuri E, et al. Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy. Neuromuscul. Disord. 2016;26(9):576&#x2013;583. doi: 10.1016/j.nmd.2016.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2016.05.016</ArticleId><ArticleId IdType="pmc">PMC5026045</ArticleId><ArticleId IdType="pubmed">27423700</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendrick KR, Baxi SC, Smith RM. Usefulness of the modified 0&#x2013;10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma. J. Emerg. Nurs. 2000;26(3):216&#x2013;222. doi: 10.1016/S0099-1767(00)90093-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0099-1767(00)90093-X</ArticleId><ArticleId IdType="pubmed">10839848</ArticleId></ArticleIdList></Reference><Reference><Citation>Solari A, et al. Reliability of clinical outcome measures in Charcot&#x2013;Marie&#x2013;Tooth disease. Neuromuscul. Disord. 2008;18(1):19&#x2013;26. doi: 10.1016/j.nmd.2007.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2007.09.006</ArticleId><ArticleId IdType="pubmed">17964785</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman T, Giladi N, Hausdorff JM. Properties of the &#x2018;timed up and go&#x2019; test: more than meets the eye. Gerontology. 2011;57(3):203&#x2013;210. doi: 10.1159/000314963.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000314963</ArticleId><ArticleId IdType="pmc">PMC3094679</ArticleId><ArticleId IdType="pubmed">20484884</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function, BDNF ALS Study Group (Phase III) J. Neurol. Sci. 1999;169(1&#x2013;2):13&#x2013;21. doi: 10.1016/S0022-510X(99)00210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JF. Spirometry in the evaluation of pulmonary function. West. J. Med. 1976;125(2):110&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1237217</ArticleId><ArticleId IdType="pubmed">969495</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S, Newton J, Niven E, Foley J, Bak TH. Screening for cognition and behaviour changes in ALS. Amyotroph. Lateral Scler. Frontotemporal Degener. 2014;15(1&#x2013;2):9&#x2013;14. doi: 10.3109/21678421.2013.805784.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.805784</ArticleId><ArticleId IdType="pubmed">23781974</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti B, et al. Cognitive-behavioral longitudinal assessment in ALS: the Italian Edinburgh Cognitive and Behavioral ALS screen (ECAS) Amyotroph. Lateral Scler. Frontotemporal Degener. 2018;19(5&#x2013;6):387&#x2013;395. doi: 10.1080/21678421.2018.1473443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1473443</ArticleId><ArticleId IdType="pubmed">29804470</ArticleId></ArticleIdList></Reference><Reference><Citation>Middel B, van Sonderen E. Statistical significant change versus relevant or important change in (quasi) experimental design: some conceptual and methodological problems in estimating magnitude of intervention-related change in health services research. Int. J. Integr. Care. 2002;2:e15. doi: 10.5334/ijic.65.</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/ijic.65</ArticleId><ArticleId IdType="pmc">PMC1480399</ArticleId><ArticleId IdType="pubmed">16896390</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>